Dataset Information

Cutaneous lymphadenoma in a young Saudi female: a case report.

ABSTRACT:

Background

Cutaneous lymphadenoma (CL) is a rare benign epithelial neoplasm. It presents as skin-colored nodule in the head and neck area. CL is an uncommon condition with less than 60 cases reported in the literature and very rare occurrence in the Asian population; it has never been previously reported in the Arabian gulf countries. We report the first case of CL in a young Saudi female.

Case description

A 28-year-old Saudi female presented with an asymptomatic skin lesion on her forehead that first appeared eight years ago. Physical examination showed a 3 mm × 3.4 mm solitary, nontender, firm, skin-colored to pink nodule with overlying telangiectasia. A biopsy was taken, and histopathology findings revealed epithelial nests of uniform, small basaloid cells with some peripheral palisading; a fibrotic stroma; and Lympho-histiocytic inflammatory infiltrates. No retraction artifacts, atypia or necrosis were observed. These findings are consistent with CL. The lesion was fully excised by skin punch biopsy without any residual tumor. No recurrence was observed after 1 year follow-up.

Conclusions

CL presents a diagnostic pitfall, and many dermatologists fail to recognize it in the initial clinical impression. Moreover, although CL is a rare and benign tumor, it must be in the differential diagnosis of any asymptomatic skin nodule in the head and neck area.

SUBMITTER: Aldihan R

PROVIDER: S-EPMC9343981 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Cutaneous lymphadenoma in a young Saudi female: a case report.

Aldihan Rema R Alsubait Norah N Alhaddab Mohammed M

AME case reports 20220725

<h4>Background</h4>Cutaneous lymphadenoma (CL) is a rare benign epithelial neoplasm. It presents as skin-colored nodule in the head and neck area. CL is an uncommon condition with less than 60 cases reported in the literature and very rare occurrence in the Asian population; it has never been previously reported in the Arabian gulf countries. We report the first case of CL in a young Saudi female.<h4>Case description</h4>A 28-year-old Saudi female presented with an asymptomatic skin lesion on he ...[more]

PMID: 35928583

Similar Datasets

Project description:BackgroundCreating appropriate and sustainable treatment plans for patients with concurrent disorders presents a challenge to psychiatrists and addiction medicine specialists alike. Although varenicline has been found to be the most effective medication for smoking cessation and abstinence when compared to results from placebo medications, nicotine patches and bupropion, caution is needed when starting patients on this medication. With the high prevalence of concurrent mental health and substance use disorders in vulnerably-housed populations in Canada, it becomes increasingly important to advocate for increased guidance and research into treating concurrent disorders.Case presentationIn this case, a young female patient provisionally diagnosed with bipolar I disorder was hospitalized for a manic episode in the context of substance use and medication noncompliance. She also endorsed a long history of tobacco, alcohol, cocaine, cannabis and ketamine use. Perceptual abnormalities, including auditory hallucinations, were not recorded at admission. In addition to being stabilized for bipolar diagnosis, the patient was started on nicotine replacement therapy on Day 7 of admission followed by initiation of varenicline for smoking cessation on Day 14 of admission. Soon after the varenicline treatment was started, the patient developed auditory hallucinations, paranoia and referential beliefs. However, her insight was intact, and she had minimal thought form disorganization. In this case, these symptoms were thought to be secondary to varenicline after the consideration of potential alternative contributors.ConclusionThe occurrence of side effects as a result of varenicline use in patients with diagnosed mental health conditions is rare and underlying psychiatric illness is not labeled as an absolute contraindication in the prescription of varenicline. However, it is important to advocate for increased guidance and research on the treatment of substance use disorders in patients with bipolar I disorder. Patients may also benefit from increased collaboration between psychiatric and addiction services as that may allow for earlier recognition and intervention of symptoms to minimize distress.

Dataset Information

Cutaneous lymphadenoma in a young Saudi female: a case report.

Background

Case description

Conclusions

Publications

Cutaneous lymphadenoma in a young Saudi female: a case report.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets